false
0001494891
0001494891
2025-08-07
2025-08-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
____________________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 7, 2025
SENSUS
HEALTHCARE, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-37714 |
|
27-1647271 |
| (State
of Incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer Identification No.) |
851
Broken Sound Pkwy., NW # 215, Boca Raton, Florida |
|
33487 |
| (Address
of principal executive offices) |
|
(Zip
Code) |
Registrant's
telephone number, including area code: (561) 922-5808
_________________________________________________
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
| Common
Stock, par value $0.01 per share |
SRTS |
Nasdaq Stock Market, LLC |
| |
|
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
SENSUS
HEALTHCARE, INC.
FORM
8-K
CURRENT
REPORT
| Item 2.02 | Results
of Operation and Financial Condition |
On August 7, 2025, Sensus Healthcare, Inc. announced via press release
its financial results for the quarter ended June 30, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report
on Form 8-K and incorporated herein by reference.
The
press release makes reference to certain non-GAAP financial measures. A reconciliation of the non-GAAP financial measures and other financial
information is provided in the press release.
The
information furnished under Item 2.02, including in Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
except as shall be expressly set forth by specific reference in such filing.
| Item 9.01 | Financial
Statements and Exhibits |
(d)
Exhibits
99.1 Press Release, dated August 7, 2025.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
SENSUS HEALTHCARE, INC. |
| |
|
|
| Date: August
7, 2025 |
By: |
/s/ Javier Rampolla |
| |
|
Javier
Rampolla |
| |
|
Chief
Financial Officer |
EXHIBIT
INDEX
| |
|
Exhibit
Number |
Description |
| 99.1 |
Press Release, dated August 7, 2025. |
